Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 351.00
Ask: 366.00
Change: 0.00 (0.00%)
Spread: 15.00 (4.274%)
Open: 358.00
High: 358.00
Low: 358.00
Prev. Close: 358.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FUM Update

7 Dec 2009 07:00

RNS Number : 6529D
City of London Investment Group PLC
07 December 2009
 



7 December 2009

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

FUNDS UNDER MANAGEMENT AS AT 30 NOVEMBER 2009

City of London Investment Group Plc (AIM: CLIG), a leading emerging markets asset management group, announces its total funds under management (FuM) quarterly. At the Group's half year end on 30 November 2009, FuM were US$4.7 billion (£2.9 billion). This compares with US$2.1 billion (£1.4 billion) at 30 November 2008, US$3.5 billion (£2.2 billion) at 31 May 2009 and US$4.0 billion (£2.4 billion) at 31 August 2009. The quarter on quarter rise of 17% in FuM (in US$ terms) compares to a 14% rise in the MSCI Emerging Markets Index (MXEF) over the same period, while year on year FuM (in US$) rose by 123%, compared to an increase in MXEF of 81%.

Unaudited profit before taxation for the six months ended 30 November 2009 stands at approximately £4.8 million, which compares to £2.7 million for the equivalent period to 30 November 2008. The monthly run-rate of unaudited pre tax profit at the current level of FuM is approximately £0.9 million. 

In November the board instructed the trustees of the Company's Employee Share Option Plan ("ESOP") to purchase up to 250,000 additional shares for the ESOP, in support of the Company's share option programme. As already announced, the trustees, in the event, acquired 100,000 shares at £3.0175 and 143,350 shares at £2.95, the latter being sourced principally from directors and staff. 

A close period for the Company began on 1 December 2009 and will end with the publication of results for the six months ended 30 November 2009 on 26th January 2010.

-ends-

For further information, please visit www.citlon.co.uk or contact:

Doug Allison (Finance Director)

Simon Hudson / Andrew Dunn

City of London Investment Group PLC

Tavistock Communications

Tel: +44 (0) 20 7860 8347

Tel: +44 (0)20 7920 3150

Jeff Keating 

Chris Sim

Singer Capital Markets Ltd

Evolution Securities Limited

Nominated Adviser & Joint Broker

Joint Broker

Tel: +44 (0)20 3205 7500

Tel: +44 (0)20 7071 4300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTTFBLTMMMMBRL
Date   Source Headline
28th Sep 20174:30 pmRNSHolding(s) in Company
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20164:40 pmRNSSecond Price Monitoring Extn
27th Jan 20164:35 pmRNSPrice Monitoring Extension
13th Jan 20169:57 amRNSHardman Issues Research Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.